Nimesulide in pharma franchise in Bihar

Nimesulide in PCD pharma franchise in Agartala

Nimesulide in top pharma company in Pune

Nimesulide in pcd pharma supplier in Jaipur

Nimesulide in phama franchise company in India
Nimesulide in phama distributor in Lucknow

Home/Products /nimesulide-100mg-md-tablet

Nimoplit MD Tablet

Composition : Nimesulide (100mg) MD Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹39/-

Nimoplit MD Tablet contains Nimesulide (100mg) in a mouth-dissolving formulation, offering rapid relief from pain and inflammation. Nimesulide belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs) and is widely used to manage acute pain, inflammation, and fever associated with various conditions.

This medication works by selectively inhibiting the enzyme cyclooxygenase-2 (COX-2), which is responsible for producing prostaglandins that cause pain and inflammation. By reducing prostaglandin synthesis, Nimoplit MD Tablet effectively alleviates discomfort and inflammation, improving the quality of life for patients.

The mouth-dissolving (MD) formulation ensures quick absorption, making it a preferred choice for individuals seeking fast-acting pain relief without the need for water. It is particularly effective in managing pain from musculoskeletal disorders, dental procedures, and post-operative conditions.

Nimoplit MD Tablet is suitable for adults and provides targeted relief, allowing for better mobility and comfort. When used as directed, it can significantly reduce pain and inflammation, enabling patients to resume their daily activities.

Read More

About the Product

Nimoplit MD Tablet contains Nimesulide (100mg) in a mouth-dissolving formulation, offering rapid relief from pain and inflammation. Nimesulide belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs) and is widely used to manage acute pain, inflammation, and fever associated with various conditions.

This medication works by selectively inhibiting the enzyme cyclooxygenase-2 (COX-2), which is responsible for producing prostaglandins that cause pain and inflammation. By reducing prostaglandin synthesis, Nimoplit MD Tablet effectively alleviates discomfort and inflammation, improving the quality of life for patients.

The mouth-dissolving (MD) formulation ensures quick absorption, making it a preferred choice for individuals seeking fast-acting pain relief without the need for water. It is particularly effective in managing pain from musculoskeletal disorders, dental procedures, and post-operative conditions.

Nimoplit MD Tablet is suitable for adults and provides targeted relief, allowing for better mobility and comfort. When used as directed, it can significantly reduce pain and inflammation, enabling patients to resume their daily activities.

Common side effects may include nausea, heartburn, dizziness, and mild gastrointestinal discomfort. Seek medical attention if severe side effects or allergic reactions occur.

Indicated for the management of acute pain, inflammation, and fever associated with conditions like arthritis, musculoskeletal disorders, and dental pain.

Use under medical supervision. Not recommended for long-term use or in individuals with liver dysfunction, peptic ulcer disease, or hypersensitivity to NSAIDs.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation